Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.

Source:http://linkedlifedata.com/resource/pubmed/id/14506196

Clin. Cancer Res. 2003 Sep 1 9 10 Pt 2 3973S-81S

Download in:

View as

General Info

PMID
14506196